Vitamin D deficiency in HIV-infected postmenopausal Hispanic and African-American women

Osteoporosis International

Volumn 22, Issue 2, 2011, Pages 477-487

  Stein, E M ^a   Yin, M T ^a   McMahon, D J ^a   Shu, A ^a   Zhang, C A ^a   Ferris, D C ^b   Colon, I ^a   Dobkin, J F ^a   Hammer, S M ^a   Shane, E ^a  

^a NewYork Presbyterian Hospital   (United States)

^b BRONX LEBANON HOSPITAL CENTER   (United States)

Author keywords

African American; Hispanic; HIV+ postmenopausal women; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ALBUMIN; ALKALINE PHOSPHATASE; AMINO TERMINAL TELOPEPTIDE; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; CREATININE; EPIDERMAL GROWTH FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LEVOTHYROXINE; MULTIVITAMIN; ORAL ANTIDIABETIC AGENT; OSTEOCALCIN; PARATHYROID HORMONE; STEROID;

ADULT; AFRICAN AMERICAN; AGE; ALBUMIN BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; ASTHMA; BODY COMPOSITION; BODY FAT; BODY MASS; BONE DENSITY; BONE STRUCTURE; BONE TURNOVER; CARDIOVASCULAR DISEASE; CD4 LYMPHOCYTE COUNT; CIGARETTE SMOKING; CLINICAL EVALUATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ETHNICITY; FEMALE; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYPERLIPIDEMIA; HYPERTENSION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MINORITY GROUP; NON INSULIN DEPENDENT DIABETES MELLITUS; PARATHYROID HORMONE BLOOD LEVEL; POSTMENOPAUSE; PRIORITY JOURNAL; SCREENING TEST; SOCIAL SUPPORT; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ABSORPTIOMETRY, PHOTON; AFRICAN AMERICANS; AGED; BONE DENSITY; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; DIETARY SUPPLEMENTS; FEMALE; HISPANIC AMERICANS; HIV INFECTIONS; HUMANS; MIDDLE AGED; NEW YORK CITY; PARATHYROID HORMONE; POSTMENOPAUSE; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 78651508519     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-010-1299-x     Document Type: Article

References (64)

1. VP Luther AM Wilkin 2007 HIV infection in older adults Clin Geriatr Med 23 567 583 10.1016/j.cger.2007.02.004 17631234 vii
2. JL Goulet SL Fultz D Rimland A Butt C Gibert M Rodriguez-Barradas K Bryant AC Justice 2007 Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity? Clin Infect Dis 45 1593 1601 10.1086/523577 18190322
3. L Desquilbet LP Jacobson LP Fried JP Phair BD Jamieson M Holloway JB Margolick 2007 HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty J Gerontol 62 1279 1286
4. L Desquilbet JB Margolick LP Fried JP Phair BD Jamieson M Holloway LP Jacobson 2009 Relationship between a frailty-related phenotype and progressive deterioration of the immune system in HIV-infected men J Acquir Immune Defic Syndr 50 299 306 10.1097/QAI.0b013e3181945eb0 19194312
5. NF Onen A Agbebi E Shacham KE Stamm AR Onen ET Overton 2009 Frailty among HIV-infected persons in an urban outpatient care setting J Infect 59 346 352 10.1016/j.jinf.2009.08.008 19706308
6. RB Effros CV Fletcher K Gebo JB Halter WR Hazzard FM Horne RE Huebner EN Janoff AC Justice D Kuritzkes SG Nayfield SF Plaeger KE Schmader JR Ashworth C Campanelli CP Clayton B Rada NF Woolard KP High 2008 Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions Clin Infect Dis 47 542 553 10.1086/590150 18627268
7. P Tebas WG Powderly S Claxton D Marin W Tantisiriwat SL Teitelbaum KE Yarasheski 2000 Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy AIDS 14 F63 F67 1:CAS:528:DC%2BD3cXis1egu7w%3D 10.1097/00002030-200003100-00005 10770534
8. SE Dolan JS Huang KM Killilea MP Sullivan N Aliabadi S Grinspoon 2004 Reduced bone density in HIV-infected women AIDS 18 475 483 10.1097/00002030- 200402200-00014 15090800
9. J Teichmann E Stephan U Lange T Discher G Friese J Lohmeyer H Stracke RG Bretzel 2003 Osteopenia in HIV-infected women prior to highly active antiretroviral therapy J Infect 46 221 227 1:STN:280:DC%2BD3s3nt1Gksg%3D%3D 10.1053/jinf.2002.1109 12799147
10. D Bruera N Luna DO David LM Bergoglio J Zamudio 2003 Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy AIDS 17 1917 1923 10.1097/00002030-200309050-00010 12960824
11. V Amorosa P Tebas 2006 Bone disease and HIV infection Clin Infect Dis 42 108 114 10.1086/498511 16323100
12. JH Arnsten R Freeman AA Howard M Floris-Moore N Santoro EE Schoenbaum 2006 HIV infection and bone mineral density in middle-aged women Clin Infect Dis 42 1014 1020 1:CAS:528:DC%2BD28Xjtlelt7k%3D 10.1086/501015 16511769
13. S Jones D Restrepo A Kasowitz D Korenstein S Wallenstein A Schneider MJ Keller 2008 Risk factors for decreased bone density and effects of HIV on bone in the elderly Osteoporos Int 19 913 918 1:STN:280:DC%2BD1czkvVSnsg%3D%3D 10.1007/s00198-007-0524-8 18071649
14. JH Arnsten R Freeman AA Howard M Floris-Moore Y Lo RS Klein 2007 Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection AIDS 21 617 623 10.1097/QAD.0b013e3280148c05 17314524
15. VA Triant TT Brown H Lee SK Grinspoon 2008 Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large US healthcare system J Clin Endocrinol Metab 93 3499 3504 1:CAS:528:DC%2BD1cXhtFChurnE 10.1210/jc.2008-0828 18593764
16. J Prior D Burdge E Maan R Milner C Hankins M Klein S Walmsley 2007 Fragility fractures and bone mineral density in HIV positive women: a case-control population-based study Osteoporos Int 18 1345 1353 1:STN:280:DC%2BD2srjtVOrsQ%3D%3D 10.1007/s00198-007-0428-7 17665239
17. CDC (2009) HIV/AIDS Surveillance Report, 2007. 19:1-63
18. MT Yin DJ McMahon DC Ferris CA Zhang A Shu R Staron I Colon J Laurence JF Dobkin SM Hammer E Shane 2010 Low bone mass and high bone turnover in postmenopausal human immunodeficiency virus-infected women J Clin Endocrinol Metab 95 620 629 1:CAS:528:DC%2BC3cXitVaisrc%3D 10.1210/jc.2009-0708 19965927
19. HA Bischoff-Ferrari B Dawson-Hughes WC Willett HB Staehelin MG Bazemore RY Zee JB Wong 2004 Effect of Vitamin D on falls: a meta-analysis JAMA 291 1999 2006 1:CAS:528:DC%2BD2cXjs1aisr0%3D 10.1001/jama.291.16.1999 15113819
20. JK Dhesi LM Bearne C Moniz MV Hurley SH Jackson CG Swift TJ Allain 2002 Neuromuscular and psychomotor function in elderly subjects who fall and the relationship with vitamin D status J Bone Miner Res 17 891 897 1:STN:280:DC%2BD383mvVSitA%3D%3D 10.1359/jbmr.2002.17.5.891 12009020
21. R Vieth 1999 Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety Am J Clin Nutr 69 842 856 1:CAS:528: DyaK1MXislGntrg%3D 10232622
22. MF Holick 2007 Vitamin D deficiency N Engl J Med 357 266 281 1:CAS:528:DC%2BD2sXotVejsbc%3D 10.1056/NEJMra070553 17634462
23. JS Adams M Hewison 2008 Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity Nat Clin Pract Endocrinol Metab 4 80 90 1:CAS:528:DC%2BD1cXovFOisA%3D%3D 10.1038/ncpendmet0716 18212810
24. JS Adams PT Liu R Chun RL Modlin M Hewison 2007 Vitamin D in defense of the human immune response Ann N Y Acad Sci 1117 94 105 1:CAS:528: DC%2BD1cXhtVGmtb0%3D 10.1196/annals.1402.036 17656563
25. PT Liu SR Krutzik RL Modlin 2007 Therapeutic implications of the TLR and VDR partnership Trends Mol Med 13 117 124 10.1016/j.molmed.2007.01.006 17276732
26. CB Stephensen GS Marquis LA Kruzich SD Douglas GM Aldrovandi CM Wilson 2006 Vitamin D status in adolescents and young adults with HIV infection Am J Clin Nutr 83 1135 1141 1:CAS:528:DC%2BD28XkvFOrtr4%3D 16685057
27. CJ Van Den Bout-Van Den Beukel L Fievez M Michels FC Sweep AR Hermus ME Bosch DM Burger B Bravenboer PP Koopmans AJ Van Der Ven 2008 Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy AIDS Res Hum Retroviruses 24 1375 1382 10.1089/aid.2008.0058
28. M Rodriguez B Daniels S Gunawardene GK Robbins 2009 High frequency of vitamin D deficiency in ambulatory HIV-positive patients AIDS Res Hum Retroviruses 25 9 14 1:CAS:528:DC%2BD1MXhsFWmsrg%3D 10.1089/aid.2008.0183 19108690
29. S Mouly KS Lown D Kornhauser JL Joseph WD Fiske IH Benedek PB Watkins 2002 Hepatic but not intestinal CYP3A4 displays dose-dependent induction by efavirenz in humans Clin Pharmacol Ther 72 1 9 1:CAS:528:DC%2BD38Xms1alsLY%3D 10.1067/mcp.2002.124519 12151999
30. Brown TT, McComsey GA (2010) Association between initiation of antiretroviral therapy with Efavirenz and decreases in 25 hydroxyvitamin D. Antiviral therapy (in press)
31. M Cozzolino M Vidal MV Arcidiacono P Tebas KE Yarasheski AS Dusso 2003 HIV-protease inhibitors impair vitamin D bioactivation to 1, 25-dihydroxyvitamin D AIDS 17 513 520 1:CAS:528:DC%2BD3sXhsVSltL8%3D 10.1097/00002030-200303070- 00006 12598771
32. CA Fux A Rauch M Simcock HC Bucher B Hirschel M Opravil P Vernazza M Cavassini E Bernasconi L Elzi H Furrer 2008 Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study Antivir Ther 13 1077 1082 1:CAS:528:DC%2BD1MXhvVKlu74%3D 19195333
33. C Haug F Muller P Aukrust SS Froland 1994 Subnormal serum concentration of 1, 25-vitamin D in human immunodeficiency virus infection: correlation with degree of immune deficiency and survival J Infect Dis 169 889 893 1:STN:280:DyaK2c7nvF2jtA%3D%3D 7907645
34. J Teichmann E Stephan T Discher U Lange K Federlin H Stracke G Friese J Lohmeyer RG Bretzel 2000 Changes in calciotropic hormones and biochemical markers of bone metabolism in patients with human immunodeficiency virus infection Metabolism 49 1134 1139 1:CAS:528:DC%2BD3cXms1yns74%3D 10.1053/meta.2000.8609 11016893
35. E Villamor 2006 A potential role for vitamin D on HIV infection? Nutr Rev 64 226 233 10.1111/j.1753-4887.2006.tb00205.x 16770943
36. Stein EM, Strain G, Sinha N, Ortiz D, Pomp A, Dakin G, McMahon DJ, Bockman R, Silverberg SJ (2008) Vitamin D insufficiency prior to bariatric surgery: risk factors and a pilot treatment study. Clin Endocrinol (Oxf)
37. AC Looker 2005 Body fat and vitamin D status in black versus white women J Clin Endocrinol Metab 90 635 640 1:CAS:528:DC%2BD2MXhsVCgsr8%3D 10.1210/jc.2004-1765 15546897
38. S Nesby-O'Dell KS Scanlon ME Cogswell C Gillespie BW Hollis AC Looker C Allen C Doughertly EW Gunter BA Bowman 2002 Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994 Am J Clin Nutr 76 187 192 12081833
39. SS Harris E Soteriades JA Coolidge S Mudgal B Dawson-Hughes 2000 Vitamin D insufficiency and hyperparathyroidism in a low income, multiracial, elderly population J Clin Endocrinol Metab 85 4125 4130 1:CAS:528:DC%2BD3cXotlWnuro%3D 10.1210/jc.85.11.4125 11095443
40. P Hellman J Albert M Gidlund L Klareskog J Rastad G Akerstrom C Juhlin 1994 Impaired parathyroid hormone release in human immunodeficiency virus infection AIDS Res Hum Retroviruses 10 391 394 1:STN:280:DyaK2czkslClsQ%3D%3D 10.1089/aid.1994.10.391 7915122
41. P Jaeger S Otto RF Speck L Villiger FF Horber JP Casez R Takkinen 1994 Altered parathyroid gland function in severely immunocompromised patients infected with human immunodeficiency virus J Clin Endocrinol Metab 79 1701 1705 1:CAS:528:DyaK2MXislWiurs%3D 10.1210/jc.79.6.1701 7989478
42. P Hellman A Karlsson-Parra L Klareskog P Ridefelt G Bjerneroth J Rastad G Akerstrom C Juhlin 1996 Expression and function of a CD4-like molecule in parathyroid tissue Surgery 120 985 992 1:STN:280:DyaK2s7hs1eqtA%3D%3D 10.1016/S0039-6060(96)80044-4 8957484
43. NH Bell 1997 Bone and mineral metabolism in African Americans Trends Endocrinol Metab 8 240 245 1:CAS:528:DyaK2sXmt1GhsLk%3D 10.1016/S1043-2760(97) 00065-9 18406811
44. LB Yanoff SJ Parikh A Spitalnik B Denkinger NG Sebring P Slaughter T McHugh AT Remaley JA Yanovski 2006 The prevalence of hypovitaminosis D and secondary hyperparathyroidism in obese Black Americans Clin Endocrinol (Oxf) 64 523 529 1:CAS:528:DC%2BD28XlvFSrsrs%3D 10.1111/j.1365-2265.2006.02502.x
45. A Benjamin A Moriakova N Akhter D Rao H Xie S Kukreja E Barengolts 2009 Determinants of 25-hydroxyvitamin D levels in African-American and Caucasian male veterans Osteoporos Int 20 10 1795 803 1:CAS:528:DC%2BD1MXhtVygt7zJ 10.1007/s00198-009-0873-6 19280273
46. MT Hannan HJ Litman AB Araujo CE McLennan RR McLean JB McKinlay TC Chen MF Holick 2008 Serum 25-hydroxyvitamin D and bone mineral density in a racially and ethnically diverse group of men J Clin Endocrinol Metab 93 40 46 1:CAS:528:DC%2BD1cXnsVOqtg%3D%3D 10.1210/jc.2007-1217 17986641
47. RP Heaney KM Davies TC Chen MF Holick MJ Barger-Lux 2003 Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol Am J Clin Nutr 77 204 210 1:CAS:528:DC%2BD3sXhtFymtA%3D%3D 12499343
48. MF Holick RM Biancuzzo TC Chen EK Klein A Young D Bibuld R Reitz W Salameh A Ameri AD Tannenbaum 2008 Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D J Clin Endocrinol Metab 93 677 681 1:CAS:528:DC%2BD1cXjsFyntL4%3D 10.1210/jc.2007-2308 18089691
49. TL Clemens JS Adams SL Henderson MF Holick 1982 Increased skin pigment reduces the capacity of skin to synthesise vitamin D3 Lancet 1 74 76 1:CAS:528:DyaL38XhvFOjs7g%3D 10.1016/S0140-6736(82)90214-8 6119494
50. E Hypponen C Power 2007 Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors Am J Clin Nutr 85 860 868 1:CAS:528:DC%2BD2sXjtleqtbs%3D 17344510
51. MF Holick 1995 Environmental factors that influence the cutaneous production of vitamin D Am J Clin Nutr 61 638S 645S 1:CAS:528:DyaK2MXltlektb4%3D 7879731
52. NH Bell S Epstein A Greene J Shary MJ Oexmann S Shaw 1985 Evidence for alteration of the vitamin D-endocrine system in obese subjects J Clin Invest 76 370 373 1:CAS:528:DyaL2MXltVaqtrk%3D 10.1172/JCI111971 2991340
53. Y Liel E Ulmer J Shary BW Hollis NH Bell 1988 Low circulating vitamin D in obesity Calcif Tissue Int 43 199 201 1:STN:280:DyaL1M%2FovFemsQ%3D%3D 10.1007/BF02555135 3145124
54. N Hamoui G Anthone PF Crookes 2004 Calcium metabolism in the morbidly obese Obes Surg 14 9 12 10.1381/096089204772787211 14980026
55. J Wortsman LY Matsuoka TC Chen Z Lu MF Holick 2000 Decreased bioavailability of vitamin D in obesity Am J Clin Nutr 72 690 693 1:CAS:528:DC%2BD3cXmsFGrsbs%3D 10966885
56. JE Compston S Vedi JE Ledger A Webb JC Gazet TR Pilkington 1981 Vitamin D status and bone histomorphometry in gross obesity Am J Clin Nutr 34 2359 2363 1:STN:280:DyaL38%2FmsFejtA%3D%3D 7304477
57. JP Reis D von Muhlen ER Miller 3rd ED Michos LJ Appel 2009 Vitamin D status and cardiometabolic risk factors in the United States adolescent population Pediatrics 124 371 379 10.1542/peds.2009-0213
58. D Bikle 2009 Nonclassic actions of vitamin D J Clin Endocrinol Metab 94 26 34 1:CAS:528:DC%2BD1MXptVKmsQ%3D%3D 10.1210/jc.2008-1454 18854395
59. DD Bikle 2008 Vitamin D and the immune system: role in protection against bacterial infection Curr Opin Nephrol Hypertens 17 348 352 1:CAS:528: DC%2BD1cXot1yjtrY%3D 10.1097/MNH.0b013e3282ff64a3 18660668
60. P Bergman L Walter-Jallow K Broliden B Agerberth J Soderlund 2007 The antimicrobial peptide LL-37 inhibits HIV-1 replication Curr HIV Res 5 410 415 1:CAS:528:DC%2BD2sXot1Onsrc%3D 10.2174/157016207781023947 17627504
61. DA de Luis P Bachiller R Aller J de Luis O Izaola MC Terroba L Cuellar M Gonzalez Sagrado 2002 Relation among micronutrient intakes with CD4 count in HIV-infected patients Nutr Hosp 17 285 289 12514921
62. SM Arpadi D McMahon EJ Abrams M Bamji M Purswani ES Engelson M Horlick E Shane 2009 Effect of bimonthly supplementation with oral cholecalciferol on serum 25-hydroxyvitamin D concentrations in HIV-infected children and adolescents Pediatrics 123 e121 e126 10.1542/peds.2008-0176 19117833
63. CJ Haug P Aukrust E Haug L Morkrid F Muller SS Froland 1998 Severe deficiency of 1, 25-dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis J Clin Endocrinol Metab 83 3832 3838 1:CAS:528: DyaK1cXntlOisb0%3D 10.1210/jc.83.11.3832 9814454
64. BW Hollis 2007 Assessment of circulating 25(OH)D and 1, 25(OH)2D: emergence as clinically important diagnostic tools Nutr Rev 65 S87 S90 10.1301/nr.2007.aug.S87-S90 17867378